APC best practices presented at ketamine forum

APC CEO Scott Brunner and PCCA’s A.J. Day attended a forum in Washington, D.C., on the emergence of ketamine as an area of therapeutic interest, sponsored by the Reagan-Udall Foundation for the FDA. The best part: AJ was part of a panel discussion regarding APC’s ketamine compounding best practices document.

APC, APhA, NCPA, and PCCA were singing from the same sheet of music last week in FDA’s annual...

The FDA held a listening session on the "Use and Processes of Advisory Committees" on Thursday....

Check out the latest post in the PCCA Blog — it’s an interview with APC’s own Jennifer Petska,...

APC best practices presented at ketamine forum

Related posts

APC, sister groups present to FDA

FDA listened, we spoke

Jen talks with PCCA